Product Information
LOTEMAX SM 0.38% OPHTH GEL is a brand product labeled by Bausch & Lomb Incorporated, priced at $49.4839 per GM under NDC 24208050707. Its NADAC has been published 363 times since Jul 17, 2019.
The High Outlier badge above means this manufacturer's average price in the loteprednol etabonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3.8 mg/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208050707
Classification
Brand
Dosage Form
GEL
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
New Drug (NDA)
FDA Application
NDA208219On Market Since
2/25/2019
Pharmacological Classes
Price Statistics
The NADAC for LOTEMAX SM 0.38% OPHTH GEL has been published 363 times since Jul 17, 2019, and over the history we have for it it has risen 35.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.4839 per GM |
|---|---|
| All-time high | $49.6720 (May 14, 2025) |
| All-time low | $36.5996 (Jul 17, 2019) |
| 52-week high | $49.5647 |
| 52-week low | $49.4681 |
| Median price | $43.6302 |
| Average price | $44.4529 |
| Largest weekly change | +6.0% (Jan 10, 2024) |
| Weeks tracked | 363 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the loteprednol etabonate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LOTEMAX SM 0.38% OPHTH GEL?
The current National Average Drug Acquisition Cost (NADAC) for LOTEMAX SM 0.38% OPHTH GEL, manufactured by Bausch & Lomb Incorporated, is $49.4839 per GM (NDC 24208050707), effective Jun 24, 2026.
How has the price of LOTEMAX SM 0.38% OPHTH GEL changed over time?
Over the history we have for it, the NADAC for LOTEMAX SM 0.38% OPHTH GEL has risen 35.2%. It has been tracked across 363 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for LOTEMAX SM 0.38% OPHTH GEL?
Since Jul 17, 2019, the NADAC for LOTEMAX SM 0.38% OPHTH GEL has ranged from a low of $36.5996 (Jul 17, 2019) to a high of $49.6720 (May 14, 2025), with a median of $43.6302 per GM.
Are there cheaper alternatives to LOTEMAX SM 0.38% OPHTH GEL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LOTEMAX SM 0.38% OPHTH GEL, so no direct lower-cost alternative is listed.
Who manufactures LOTEMAX SM 0.38% OPHTH GEL?
LOTEMAX SM 0.38% OPHTH GEL (NDC 24208050707) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.
Related Drugs
Same classification